Am J Trop Med Hyg. 2021 Feb 22;104(4):1438-1443. doi: 10.4269/ajtmh.20-1398.
Current chikungunya antibody prevalence and titers are likely to differ based on the exposure rates before the 2006 reemergence in India. For vaccine usage, such data are of immense importance. This study addresses age-stratified IgG titers and its subtypes in Pune, India, endemic for the disease. 170 age-stratified serum pools from 791 individuals with prior chikungunya exposure, and 15 samples from acute disease phase were analyzed. An indirect ELISA based on inactivated chikungunya virus was used to determine anti-CHIKV-IgG and its subtypes. Neutralizing antibody titers (plaque reduction neutralization test [PRNT]) were compared with binding antibody titers (ELISA). Anti-CHIKV-IgG titers along with IgG1 and IgG4 increased till the age-group of until 11-15 years and remained comparable thereafter till > 65 years. IgG1 was the predominant IgG subtype detected in all the pools, whereas IgG4 was present in 151/170 pools. Strong positive correlation of IgG1 was obtained with CHIKV-PRNT50 titers. None of the sample had anti-CHIKV-IgG2, whereas five pools had IgG3 antibody. In the acute-phase serum sample, IgG1 was present in all the samples, whereas IgG4 was present in 8/15 samples. IgG4 was predominant in four samples. During acute phase and at different times postinfection, IgG1 circulated in high titers followed by IgG4. Higher antibody titers in adults reflect reexposures. The data will prove useful in assessing immune response to CHIKV vaccine in relation to IgG subtype.
目前,由于在 2006 年印度再次爆发之前的暴露率不同,可能会导致基孔肯雅抗体的流行率和滴度有所不同。对于疫苗的使用,这些数据非常重要。本研究旨在探讨印度普纳地区基孔肯雅病流行地区按年龄分层的 IgG 滴度及其亚型。对 791 名有基孔肯雅病毒既往暴露史的个体进行了 170 个年龄分层血清池分析,其中包括 15 个急性疾病阶段的样本。采用基于灭活基孔肯雅病毒的间接 ELISA 来确定抗-CHIKV-IgG 及其亚型。中和抗体滴度(蚀斑减少中和试验[PRNT])与结合抗体滴度(ELISA)进行比较。抗-CHIKV-IgG 滴度以及 IgG1 和 IgG4 一直增加到 11-15 岁年龄组,此后直到>65 岁时保持可比。在所有的血清池中都检测到 IgG1 是主要的 IgG 亚型,而 IgG4 存在于 151/170 个血清池中。IgG1 与 CHIKV-PRNT50 滴度呈强正相关。没有样本具有抗-CHIKV-IgG2,而 5 个样本具有 IgG3 抗体。在急性血清样本中,所有样本均存在 IgG1,而 15 个样本中的 8 个样本存在 IgG4。在 4 个样本中 IgG4 占优势。在急性期和感染后不同时间,IgG1 以高滴度循环,随后是 IgG4。成人中的高抗体滴度反映了再暴露。这些数据将有助于评估与 IgG 亚型相关的 CHIKV 疫苗的免疫反应。